Shandong Buchang Pharmaceuticals (603858.SH) has spent 528 million yuan to repurchase 3.03% of its shares.

18:05 18/09/2024

BuXiang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has completed the central competitive bidding...

Shandong Buchang Pharmaceuticals (603858.SH) announced that as of September 18, 2024, the company has repurchased a total of 33.5555 million shares through centralized bidding trading. The repurchased shares account for 3.03% of the company's total share capital. The highest purchase price was 17.44 yuan per share and the lowest purchase price was 14.16 yuan per share. The total amount paid for the repurchases so far is 528 million yuan (excluding transaction fees).

HK Stock Market Move | Commercial aerospace concept stocks fell significantly, with Goldwind Science & Technology (02208) dropping more than 8% and APT SATELLITE (01045) falling over 5%.

HK Stock Market Move | Brain-machine concept strengthens, Nanjing Panda (00553) rises over 15%, Musk states brain-machine devices to start "mass production" this year

CITIC SEC: Exchange rate appreciation transmits profit end, emphasizing once again the importance of "focusing on the turning point of airline profitability"

HK Stock Market Move | Commercial aerospace concept stocks fell significantly, with Goldwind Science & Technology (02208) dropping more than 8% and APT SATELLITE (01045) falling over 5%.

HK Stock Market Move | Brain-machine concept strengthens, Nanjing Panda (00553) rises over 15%, Musk states brain-machine devices to start "mass production" this year

CITIC SEC: Exchange rate appreciation transmits profit end, emphasizing once again the importance of "focusing on the turning point of airline profitability"